Collegium Pharmaceutical, Inc. Common Stock Quote & Summary Data
Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don’t know the stock symbol? Use the Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.
“Best Ask” is the lowest price currently being asked for a block of stock.
“Today’s Low” The lowest sales price the stock has fallen to during the regular trading hours, the intra-day low.
“52 Week Low” is the lowest sales price the stock has fallen to during the regular trading hours during the most recent 52 week period.
Prices during the When Issued trading period are used in the 52 week high/low calculation.
Company Description (as filed with the SEC)
We are a specialty pharmaceutical company developing and commercializing next-generation abuse-deterrent products that incorporate our patented DETERx platform technology for the treatment of chronic pain and other diseases. Our first product, Xtampza, is an abuse-deterrent, extended-release, oral formulation of oxycodone, a widely prescribed opioid medication. In April 2016, the U.S. Food and Drug Administration, or FDA, approved our new drug application, or NDA, filing for Xtampza for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Certain human abuse potential studies are included in the approved label, as well as data supporting the administration of the product as a sprinkle or administered through feeding tubes. In June 2016, we announced the commercial launch of Xtampza. . More .
Where does COLL fit in the risk graph?